Home > Journals > Minerva Chirurgica > Past Issues > Minerva Chirurgica 2009 February;64(1) > Minerva Chirurgica 2009 February;64(1):37-44

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA CHIRURGICA

A Journal on Surgery


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,877


eTOC

 

REVIEWS  ORGAN TRANSPLANTATION


Minerva Chirurgica 2009 February;64(1):37-44

language: English

Lung transplantation: past, present, and future

Yun J. J, Mason D. P.

Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, OH, USA


PDF  


Lung transplantation (LTx) is an established therapy for end-stage lung disease (ESLD). Survival after LTx is limited by infection and rejection, particularly bronchiolitis obliterans syndrome (BOS). New techniques with the potential to increase donor lung supply and prevent rejection continue to evolve. These developments hold promise for improved outcomes for a greater number of patients.

top of page

Publication History

Cite this article as

Corresponding author e-mail